Evaluation of aminoglycoside modifying enzymes, SCCmec, coagulase gene and PCR-RFLP coagulase gene typing of Staphylococcus aureus isolates from hospitals in Shiraz, southwest of Iran.

Staphylococcus aureus is an important human pathogen that causes various infections. Aminoglycosides are broad-spectrum antibiotics used to treat methicillinresistant S. aureus (MRSA) infections. Typing of S. aureus isolates by coagulase gene typing and PCR-RFLP coa gene is a fast and suitable method for epidemiological studies. Aim of the present study was to evaluate the resistance to aminoglycosides, staphylococcal chromosomal cassette mec (SCCmec) types, coagulation typing and PCR-RFLP coa gene in clinical isolates of S. aureus. 192 S. aureus isolates were collected from Namazi and Shahid Faghihi hospitals. Antibiotic resistance was measured by disk diffusion method and MIC was determined for gentamicin. The presence of genes encoding aminoglycoside modifying enzymes (AME) and mecA gene were assessed by PCR. Also the coagulase typing, PCR-RFLP coa gene, and SCCmec typing were performed. Out of 192 isolated S. aureus isolates, 83 (43.2%) MRSA isolates were identified. In this study, a high resistance to streptomycin and gentamicin (98.7%) were observed. Among the AME genes, the aac (6')-Ie-aph (2″) gene was the most common. Based on the SCCmec typing, it was determined that the prevalence of SCCmec type III (45.8%) was highest. From the amplification of the coa gene, 5 different types were obtained. Also, in digestion of coa gene products by HaeIII enzyme, 10 different RFLP patterns were observed. According to this study, aminoglycoside resistance is increasing among MRSA isolates. As a result, monitoring and control of aminoglycoside resistance can be effective in the treatment of MRSA isolates. Also, typing of S. aureus isolates based on coagulase gene polymorphism is a suitable method for epidemiological studies.

Reproductive efficiency of treated Karakul ewes with short-term progesterone and hCG injections during the non-breeding and breeding seasons.

The aim of this study was to evaluate reproductive efficiency of ewes following a short-term treatment with progesterone (P4) plus human chorionic gonadotropin (hCG) injections. In Exp 1, ewes (n = 65) were used during the non-breeding season and received P4, three times every other day (n = 22, 3PHCG, IM) or a single dose of P4 (n = 21, PHCG). We injected hCG in all ewes 24 h after the P4 treatment, and distilled water in control group (n = 22). Blood collection were performed on days -13, -6 and + 8 relative to ram release. In Exp 2, during the breeding season, ewes (n = 66) were assigned to the 3PHCG (n = 33) and control (n = 33) groups described for Exp 1, and subsequently received PGF2α 48 h before ram release. Pregnancy diagnosis was performed on day 42 after the ram release which was done 24 h after the hCG injection. In Exp 1, Estrus, pregnancy rate at induced estrus, and lambing rates at the first cycle were greater in 3PHCG (81.8%, 59.1% and 54.5%) group compared with the PHCG (38.1%, 23.8% and 19%) and control (0%, 0% and 0%) groups (P < 0.05). In Exp 2, Estrus, pregnancy rate at induced estrus, and lambing rates at the first cycle were greater in 3PHCG (75.8%, 57.6% and 51.5%) group compared with the control (39.4%, 30.3% and 27.3%) groups (P < 0.05). To conclude, hCG injection 24 h after P4 administration is an effective protocol to induce fertile estrus during non-breeding season, and synchronize estrus and lambing of ewe in the breeding season.